Mississippi Healthcare
Compliance Guide

Mississippi presents a unique and evolving regulatory landscape for healthcare companies, balancing a traditionally conservative approach with recent advancements in telehealth adoption. The state has made significant strides in embracing telehealth, particularly accelerated by the COVID-19 pandemic, leading to more permissive regulations regarding its use and reimbursement. Key regulatory bodies include the Mississippi State Board of Medical Licensure (MSBML), the Mississippi Board of Nursing, and the Mississippi Board of Pharmacy. These boards are instrumental in interpreting and enforcing professional practice acts, telehealth guidelines, and prescribing rules. The overall business climate for healthcare operations, while still navigating the complexities of a robust Corporate Practice of Medicine (CPOM) doctrine, has seen some modernization to accommodate innovative care models. Recent legislative actions, such as the amendments to the Mississippi Telehealth Act, underscore the state's commitment to expanding access to care through technology. However, companies must remain vigilant regarding the strict enforcement of professional licensure requirements, the prohibition against fee-splitting, and the nuanced application of CPOM, which significantly impacts ownership and operational structures. Mississippi's regulatory environment, while becoming more telehealth-friendly, still requires a meticulous approach to ensure compliance, especially for multi-state operators and those introducing novel healthcare services. The state's emphasis on in-state licensure and the establishment of a bona fide practitioner-patient relationship prior to prescribing, particularly for controlled substances, remains a cornerstone of its regulatory framework. Businesses must also pay close attention to the specific scope of practice for various licensed professionals, as this dictates the services that can be legally provided and under what supervision.

Mississippi maintains a robust and generally restrictive Corporate Practice of Medicine (CPOM) doctrine, primarily rooted in case law and the interpretation of professional licensing statutes. While there isn't a single overarching statute explicitly prohibiting CPOM, the MSBML and the Mississippi Attorney General's office have consistently held that only licensed physicians or professional medical corporations (PC) owned by physicians can practice medicine. This doctrine prevents unlicensed individuals or entities from employing physicians or otherwise controlling the practice of medicine. The legal basis for Mississippi's CPOM stems from the Medical Practice Act, Miss. Code Ann. § 73-25-1 et seq., which defines the practice of medicine and limits it to licensed individuals. The underlying rationale is to protect patient welfare by ensuring that medical decisions are made by qualified professionals, free from commercial influence.

Ownership Structures:

• Physician-Owned Entities: Only professional corporations (PC) or professional limited liability companies (PLLC) where all owners are licensed physicians are typically permitted to practice medicine. These entities must be registered with the Mississippi Secretary of State and comply with specific professional entity statutes.
• Non-Physician Ownership: Generally, non-physicians or lay corporations cannot own or control entities that engage in the practice of medicine. This means a general business corporation cannot employ physicians to provide medical services or dictate clinical protocols. This restriction extends to medspas, dental practices, and wellness clinics that offer services considered the practice of medicine or dentistry.

Specific Restrictions:

• Employment of Physicians: Lay entities cannot directly employ physicians to provide medical services. This is a core tenet of CPOM enforcement.
• Control over Clinical Decisions: Non-physician entities cannot exert control over a physician's independent medical judgment or clinical decisions.
• Fee-Splitting: Mississippi law strictly prohibits fee-splitting, where a professional shares a percentage of their professional fees with an unlicensed individual or entity in exchange for patient referrals or other services. This is codified in Miss. Code Ann. § 73-25-34(1)(f), which considers such acts as unprofessional conduct.

Impact on Telehealth Companies, Medspas, Dental Practices, and Wellness Clinics:

• Telehealth Companies: To comply with CPOM, telehealth companies often utilize a Management Services Organization (MSO) model. The MSO (a lay entity) provides administrative, non-clinical services (e.g., technology, marketing, billing) to a physician-owned professional entity, which directly employs or contracts with the physicians providing medical care. The MSO cannot control clinical decisions or engage in fee-splitting.
• Medspas: Medspas offering medical services (e.g., injectables, laser treatments, IV therapy) must be owned by a licensed physician or operate under a strict MSO model where the medical services are provided by a physician-owned professional entity. Non-physician ownership of the medical practice component is generally prohibited.
• Dental Practices: Similar to medical practices, dental practices must be owned by licensed dentists, typically structured as professional corporations or PLLCs. Lay ownership is prohibited.
• Wellness Clinics: If a wellness clinic offers services that fall under the definition of practicing medicine (e.g., hormone therapy, GLP-1 prescriptions, medical weight loss), it must adhere to the same CPOM restrictions, requiring physician ownership or a compliant MSO structure. Services that are purely non-medical (e.g., fitness coaching, non-medical nutrition advice) are not subject to CPOM.

Companies seeking to operate in Mississippi must carefully structure their operations to ensure that the professional medical services component is legally separate and controlled by licensed professionals, while administrative services can be provided by a separate, compliant MSO.

Mississippi has significantly expanded its telehealth regulations, particularly through the Mississippi Telehealth Act, Miss. Code Ann. § 83-9-351 et seq., which was amended to reflect a more permissive stance. The state generally allows for the establishment of a bona fide practitioner-patient relationship via telehealth, provided certain conditions are met.

Establishment of Practitioner-Patient Relationship:

• A practitioner-patient relationship can be established through telehealth, meaning an in-person visit is not strictly required to initiate care. However, the standard of care remains the same as for in-person encounters. The MSBML's regulations (Miss. Admin. Code 23-20-0001 et seq.) emphasize that the physician must be able to conduct an appropriate assessment and diagnosis using telehealth technologies.

Permitted Modalities:

• Live Interactive Audio-Visual (Video): This is the preferred modality for establishing new patient relationships and conducting complex assessments, as it allows for real-time visual and auditory interaction. It is widely accepted for most telehealth services.
• Live Interactive Audio-Only (Telephone): While historically more restricted, Mississippi has expanded the use of audio-only telehealth, particularly post-pandemic. It can be used for follow-up care, mental health services, and in situations where video is not available or appropriate, provided the standard of care can be met. However, initial establishment of a relationship for certain conditions, especially those requiring physical examination, may still necessitate video or in-person.
• Asynchronous (Store-and-Forward): This modality involves the transmission of recorded health information (e.g., images, pre-recorded video, data) to a practitioner for review at a later time. It is permitted for specific applications, such as dermatology or radiology, where a diagnosis can be made without real-time interaction. It is generally not sufficient for establishing an initial practitioner-patient relationship for complex medical conditions or for prescribing controlled substances without prior live interaction.

Telehealth Registration Requirements:

• Mississippi does not have a separate 'telehealth license' or specific registration requirement for out-of-state providers to practice telehealth into Mississippi, beyond the standard professional licensure. Any physician, nurse practitioner, or physician assistant providing telehealth services to a patient located in Mississippi must hold a full, unrestricted Mississippi license for their respective profession. Participation in multi-state compacts (e.g., Interstate Medical Licensure Compact for physicians, Nurse Licensure Compact for nurses) facilitates licensure but does not negate the need for a Mississippi license or privilege to practice.

Informed Consent Requirements:

• Prior to providing telehealth services, practitioners must obtain informed consent from the patient. This consent should include information about the nature of telehealth, its limitations, potential risks, and the patient's rights, including the right to withdraw consent. The consent process must be documented in the patient's medical record. While specific language is not statutorily mandated, it should generally cover privacy, security, data transmission, and emergency protocols.

Geographic Restrictions:

• There are no specific geographic restrictions within Mississippi for the provision of telehealth services. Services can be provided to patients located anywhere within the state, provided the practitioner is appropriately licensed in Mississippi.

Mississippi's prescribing rules for telehealth, particularly concerning controlled substances, are stringent and align with federal regulations while adding state-specific requirements. The Mississippi State Board of Medical Licensure (MSBML) and the Mississippi Board of Pharmacy oversee these regulations.

Controlled Substances Prescribing via Telehealth:

• Schedules Permitted: Generally, all schedules of controlled substances (Schedules II, III, IV, V) can be prescribed via telehealth, provided a bona fide practitioner-patient relationship has been established, and the prescribing physician adheres to the standard of care applicable to in-person encounters. However, the initial establishment of this relationship for controlled substances often requires a more robust assessment.
• Bona Fide Practitioner-Patient Relationship: For controlled substances, the MSBML emphasizes that the relationship must be established through an appropriate evaluation, which may include a physical examination. While the Mississippi Telehealth Act allows for the establishment of this relationship via telehealth, for controlled substances, especially Schedule II, a comprehensive assessment, often involving real-time audio-visual interaction, is critical. Prescribing based solely on an online questionnaire or asynchronous communication for controlled substances is generally not permissible.
• DEA Requirements: Prescribers must comply with all federal Drug Enforcement Administration (DEA) requirements. This includes having a valid DEA registration associated with their Mississippi practice location. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before prescribing controlled substances via the internet, with certain exceptions (e.g., public health emergencies, specific telemedicine exceptions). While the DEA's proposed rules for a permanent telemedicine exception are pending, Mississippi's state law generally requires a robust evaluation, which aligns with the spirit of Ryan Haight.
• PDMP Checking: Mississippi mandates the use of its Prescription Drug Monitoring Program (PDMP), known as the Mississippi Prescription Monitoring Program (MS PMP), before prescribing Schedule II, III, IV, and V controlled substances. Physicians must check the MS PMP database for each patient prior to prescribing an opioid or benzodiazepine and periodically thereafter. Miss. Code Ann. § 73-21-175 requires this check. This applies equally to telehealth encounters.
• Quantity and Refill Limitations: State laws impose quantity and refill limitations for certain controlled substances. For example, initial opioid prescriptions for acute pain are often limited to a specific number of days (e.g., 5-7 days), with exceptions for chronic pain or specific medical conditions. Refills for Schedule II substances are generally prohibited, while Schedule III-V substances may have up to five refills within six months. These limitations apply regardless of whether the prescription originates from an in-person or telehealth encounter.
• Special Rules for Specific Drug Classes:
  • GLP-1s (e.g., Ozempic, Wegovy): While not controlled substances, GLP-1s are potent medications. Prescribing via telehealth requires a comprehensive medical evaluation, including patient history, physical assessment (which may be challenging via telehealth), and appropriate diagnostic testing to ensure medical necessity and rule out contraindications. Off-label prescribing must be based on sound medical evidence and patient-specific needs.
  • Testosterone/Hormone Therapy: Prescribing testosterone or other hormone therapies via telehealth requires a thorough diagnostic workup, including lab tests, and a detailed assessment of the patient's medical history. Misuse potential and the need for ongoing monitoring necessitate careful adherence to the standard of care.
  • Stimulants (e.g., Adderall, Ritalin): As Schedule II controlled substances, stimulants for ADHD or narcolepsy have the most stringent prescribing requirements. An initial in-person or robust real-time audio-visual evaluation, including a comprehensive psychiatric and medical history, is typically expected. Ongoing monitoring and follow-up are essential. Prescribing based solely on asynchronous communication or questionnaires is highly risky and likely non-compliant.

Prescribers must exercise extreme caution and ensure that telehealth technology allows for an assessment equivalent to an in-person visit when prescribing controlled substances, particularly Schedule II, and always prioritize patient safety and adherence to the standard of care.

Mississippi's scope of practice laws define the services that various healthcare professionals can legally provide, impacting the operational models of healthcare companies, especially those utilizing mid-level providers. The Mississippi State Board of Medical Licensure (MSBML), Mississippi Board of Nursing, and Mississippi Board of Pharmacy govern these scopes.

Nurse Practitioners (NPs):

• Full Practice Authority: No, Mississippi does not grant full practice authority to Nurse Practitioners. NPs in Mississippi operate under a collaborative practice agreement with a supervising physician. Miss. Code Ann. § 73-15-20(5) defines the practice of a nurse practitioner as requiring a written collaborative practice agreement.
• Collaborative Practice Agreements: A written collaborative practice agreement is mandatory for NPs to practice. This agreement outlines the scope of practice, the physician's responsibilities, and the protocols for consultation, referral, and supervision. The supervising physician must be actively engaged in the practice of medicine in Mississippi. The agreement must be filed with the Board of Nursing and the MSBML. The ratio of NPs to supervising physicians is typically limited.
• Prescribing Authority: NPs have prescribing authority for legend drugs and controlled substances (Schedules II-V) under their collaborative practice agreement. Prescriptions for Schedule II controlled substances require the supervising physician's name and DEA number on the prescription, in addition to the NP's. The NP's prescribing is limited by the terms of the collaborative agreement and the supervising physician's scope of practice.

Physician Assistants (PAs):

• Independent Practice: No, PAs in Mississippi do not practice independently. They must practice under the supervision of a licensed physician. Miss. Code Ann. § 73-26-1 et seq. governs PA practice.
• Supervision Requirements: PAs operate under a 'supervising physician' relationship, which requires a written supervision agreement filed with the MSBML. The agreement outlines the PA's scope of practice, which is delegated by the supervising physician and must be within the physician's own scope of practice. The supervising physician is responsible for the PA's actions. The level of supervision required can vary depending on the PA's experience and the complexity of the tasks, but generally requires the physician to be readily available for consultation.
• Prescribing Authority: PAs have prescribing authority for legend drugs and controlled substances (Schedules II-V) as delegated by their supervising physician and outlined in their supervision agreement. Similar to NPs, prescriptions for Schedule II controlled substances often require the supervising physician's name and DEA number. The PA's prescribing is limited by the supervising physician's delegation and scope.

Other Mid-Level Providers and Delegation Rules:

• Registered Nurses (RNs) and Licensed Practical Nurses (LPNs): These professionals operate within their defined scope of practice under the Mississippi Board of Nursing. They can perform delegated medical tasks that do not require independent medical judgment, under the direction or supervision of a physician or NP/PA.
• Medical Assistants (MAs) in Medspas: MAs in Mississippi are generally considered unlicensed assistive personnel. Their scope of practice is limited to administrative and basic clinical tasks (e.g., taking vital signs, preparing patients for exams). They cannot perform tasks that constitute the practice of medicine, such as administering injectables (e.g., Botox, fillers), performing laser treatments, or IV therapy. These procedures must be performed by a licensed physician, NP, or PA, or delegated to an RN under direct supervision, where appropriate. Delegation to an MA for such procedures is strictly prohibited and would constitute the unlicensed practice of medicine.
• Delegation Rules: Any delegation of medical tasks must be to a qualified, licensed professional (e.g., RN, NP, PA) and must be within the delegating practitioner's scope of practice and the delegatee's legal scope. Direct supervision is often required for delegated tasks, particularly in settings like medspas. Improper delegation can lead to disciplinary action for both the delegating practitioner and the entity.

Navigating Mississippi's Corporate Practice of Medicine (CPOM) doctrine is paramount when structuring healthcare businesses. The primary compliant structure for lay-owned entities involved in healthcare is the Management Services Organization (MSO) model.

PC-MSO Structures:

• When Needed: The PC-MSO model is essential whenever a non-physician individual or entity (the MSO) wishes to participate in the business operations of a medical practice that provides services falling under the definition of 'practicing medicine' in Mississippi. This includes telehealth companies, medspas, dental practices, and wellness clinics offering medical services. The MSO provides non-clinical administrative and management services, while the clinical services are provided by a separate, physician-owned professional entity (the PC).
• Professional Corporation (PC) Requirements: The PC (or PLLC) must be owned entirely by licensed Mississippi physicians (or dentists for dental practices). This entity directly employs or contracts with the physicians, NPs, and PAs who provide clinical care. The PC holds the necessary licenses and permits for the medical practice. Its corporate name must typically include 'P.A.' or 'P.C.' or 'PLLC' as required by Miss. Code Ann. § 79-9-1 et seq. for professional corporations.
• Management Services Organization (MSO): The MSO is a separate, lay-owned entity (e.g., an LLC or C-Corp) that provides administrative, non-clinical services to the PC. These services typically include billing, scheduling, marketing, IT support, facilities management, equipment leasing, and non-clinical personnel. The MSO charges the PC a fair market value (FMV) fee for these services, documented in a Management Services Agreement (MSA).

Fee-Splitting Rules:

• Mississippi has strict anti-fee-splitting laws. Miss. Code Ann. § 73-25-34(1)(f) considers 'division of fees' an act of unprofessional conduct, which can lead to disciplinary action against a physician's license. This prohibits a physician from sharing a percentage of their professional fees with an unlicensed individual or entity in exchange for patient referrals or other services. The MSO's compensation from the PC must be a fixed fee or a fee structured in a way that does not constitute fee-splitting (e.g., not a percentage of professional fees or revenue directly tied to patient volume or specific procedures). Compensation should be based on the FMV of the services provided by the MSO.

Management Services Agreement (MSA) Requirements:

• The MSA is the foundational document of the PC-MSO structure. It must clearly delineate the services provided by the MSO, the compensation structure, and explicitly state that the MSO has no control over clinical decision-making. Key provisions include:
  • Scope of Services: Detailed list of administrative services provided by the MSO.
  • Compensation: Must be FMV and not tied to professional fees or patient volume to avoid fee-splitting. Often structured as a fixed monthly fee, cost-plus, or per-service fee for administrative tasks.
  • Clinical Control: Explicitly state that the PC retains sole control over all medical and clinical decisions, hiring/firing of clinical staff, and patient care.
  • Term and Termination: Standard contractual provisions.
  • Compliance: Affirmation of compliance with all applicable laws, including CPOM and anti-kickback statutes.

Structuring Ownership for Compliance:

• Physician Ownership: Ensure the entity providing medical services (the PC) is 100% owned by licensed Mississippi physicians. For multi-state operations, each state's medical entity must be owned by physicians licensed in that state.
• Clear Separation of Roles: Maintain a clear operational and legal distinction between the MSO's administrative functions and the PC's clinical functions. The MSO should not market itself as providing medical services.
• FMV Compensation: All financial arrangements between the MSO and PC must be at fair market value and commercially reasonable, documented appropriately, to avoid violating anti-kickback statutes and fee-splitting prohibitions.
• No Control Over Clinical Judgment: The MSO must not interfere with or influence the professional judgment of the physicians or other licensed practitioners. This is a critical aspect of CPOM compliance.

Failure to meticulously adhere to these structuring principles can lead to severe penalties, including license revocation, fines, and civil or criminal charges for the unlicensed practice of medicine or fee-splitting.

Mississippi's regulatory landscape is dynamic, with ongoing legislative and board activities impacting healthcare operations, particularly in telehealth and prescribing.

Legislative Actions (2024-2026):

• Telehealth Expansion: While significant telehealth reforms occurred post-COVID-19, legislative efforts continue to solidify and potentially expand these changes. Bills are often introduced to clarify reimbursement parity for telehealth services, ensuring private payers cover telehealth at rates comparable to in-person services. Companies should monitor proposed amendments to Miss. Code Ann. § 83-9-351 et seq. for further clarity on modality use, originating site requirements, and provider types.
• CPOM Clarifications: There is ongoing discussion, though no immediate legislative action, regarding potential statutory clarifications or amendments to Mississippi's CPOM doctrine. While a full repeal is unlikely, industry groups advocate for carve-outs or clearer guidance for specific innovative care models. Any proposed legislation in this area would be highly significant for non-physician owned healthcare businesses.
• Controlled Substance Prescribing: Expect continued legislative focus on opioid prescribing guidelines, including potential updates to initial prescription limits for acute pain and enhanced PDMP utilization mandates. There may also be discussions around the state's stance on medication-assisted treatment (MAT) and its accessibility via telehealth.

Recent Board Actions or Enforcement Cases:

• MSBML Enforcement: The Mississippi State Board of Medical Licensure (MSBML) remains active in enforcing CPOM and professional practice standards. Recent enforcement actions have targeted physicians involved in arrangements deemed to violate CPOM (e.g., physicians allowing lay entities to control their practice or engaging in impermissible fee-splitting). There have also been cases related to inappropriate prescribing of controlled substances via telehealth, especially when a proper practitioner-patient relationship was not adequately established or PDMP checks were omitted.
• Board of Nursing: The Mississippi Board of Nursing continues to enforce collaborative practice agreement requirements for NPs, ensuring proper supervision and adherence to scope of practice. Cases often involve NPs practicing outside the bounds of their agreement or without a valid, filed agreement.
• Telehealth Misconduct: Boards have disciplined providers for failing to meet the standard of care in telehealth, particularly for prescribing without adequate evaluation, including instances where patients were not physically located in Mississippi at the time of the encounter, leading to unlicensed practice.

Compact Participation Updates:

• Interstate Medical Licensure Compact (IMLC): Mississippi is a member of the IMLC, which streamlines the process for eligible physicians to obtain licenses in multiple participating states. This significantly aids telehealth companies in credentialing physicians for Mississippi. While the IMLC simplifies licensure, it does not alter Mississippi's specific practice or prescribing rules.
• Nurse Licensure Compact (NLC): Mississippi is also a member of the NLC, allowing RNs and LPNs licensed in other compact states to practice in Mississippi under a multi-state license. This is crucial for telehealth nursing services. NPs, however, still require a Mississippi NP license and a collaborative practice agreement.
• Physical Therapy Compact / Psychology Interjurisdictional Compact (PSYPACT): Mississippi's participation in other healthcare compacts is expanding, facilitating multi-state practice for various allied health professionals, which can indirectly support broader telehealth service offerings.

Entering the Mississippi healthcare market, particularly with telehealth or innovative models, requires meticulous planning and adherence to state-specific regulations. Here's actionable guidance:

Step-by-Step Compliance Checklist:

1. Entity Formation: For clinical services, establish a Mississippi Professional Corporation (PC) or Professional Limited Liability Company (PLLC) owned 100% by Mississippi-licensed physicians. For administrative services, form a separate, lay-owned MSO (e.g., LLC or C-Corp).
2. Licensure: Ensure all clinical providers (physicians, NPs, PAs) hold current, unrestricted Mississippi licenses. Verify compact privileges for nurses and IMLC for physicians. Out-of-state providers must obtain Mississippi licensure.
3. CPOM Compliance: Draft a robust Management Services Agreement (MSA) between the MSO and PC. Ensure the MSA clearly defines administrative services, sets FMV compensation (not percentage-based), and explicitly states the PC retains sole clinical control.
4. Telehealth Protocols: Develop comprehensive telehealth policies and procedures. These must cover patient identification, informed consent, privacy/security, emergency protocols, and documentation standards. Ensure modalities used meet state requirements for establishing a practitioner-patient relationship.
5. Prescribing Compliance: Implement strict prescribing policies, especially for controlled substances. Mandate MS PMP checks for all controlled substance prescriptions. Ensure providers understand and adhere to state-specific quantity limits and refill rules. Avoid prescribing controlled substances based solely on asynchronous communication.
6. Scope of Practice: Verify that all mid-level providers (NPs, PAs) have current, state-compliant collaborative or supervision agreements filed with the respective boards. Ensure they practice strictly within their defined scope and the terms of their agreements.
7. Anti-Kickback/Fee-Splitting: Review all financial arrangements, including marketing agreements, to ensure compliance with anti-kickback statutes and the strict prohibition against fee-splitting.
8. Data Security: Implement HIPAA-compliant data security measures for all patient information.

Common Pitfalls to Avoid:

• Ignoring CPOM: Assuming a lay entity can employ physicians or control clinical decisions is a major violation.
• Improper MSO Structure: Using an MSA that is not at FMV, includes fee-splitting, or grants the MSO clinical control.
• Inadequate Licensure: Providers practicing without a Mississippi license or appropriate compact privileges.
• Lax Prescribing: Prescribing controlled substances without a thorough evaluation, proper practitioner-patient relationship, or failing to check the MS PMP.
• Out-of-Scope Practice: Allowing NPs, PAs, or MAs to perform services outside their legal scope or without proper supervision/collaboration.
• Lack of Informed Consent: Failing to obtain and document comprehensive informed consent for telehealth services.

Timeline Expectations for Licensing and Setup:

• Entity Formation (MSO/PC): 2-4 weeks (Secretary of State filings).
• Provider Licensure: 2-6 months for new Mississippi licenses (varies by board and applicant completeness). IMLC/NLC can expedite, but still requires processing time.
• Collaborative/Supervision Agreements: 1-2 months for drafting, filing, and approval by boards.
• Policy & Procedure Development: Ongoing, but initial drafts 1-2 months.
• Full Operational Readiness: 4-9 months, depending on complexity and speed of licensure/approvals.